Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed Apr 14, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells Shares
What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), reported sales of a total of 8,125 shares (dispositions) in April 2026, generating approximately $38,403. Transactions listed:
- 2026-04-10: 3,725 shares disposed at a reported average price of $4.68 for $17,441.
- 2026-04-13: 1,000 shares disposed at a reported average price of $4.76 for $4,764.
- 2026-04-13: 3,400 shares disposed at a reported average price of $4.76 for $16,198.
These were sales (not purchases) and are routine disposals rather than affirmative insider purchases.
Key Details
- Transaction dates and prices: Apr 10 (3,725 @ $4.68), Apr 13 (1,000 @ $4.76; 3,400 @ $4.76). Total shares sold: 8,125; total proceeds: ~$38,403.
- Footnotes indicate the sales were to satisfy tax withholding on RSU vesting (footnote F1) and were made pursuant to a pre‑established Rule 10b5‑1(c) trading plan (footnote F4), i.e., non‑discretionary.
- Reported prices are weighted averages; the filing notes sale prices ranged roughly from $4.61 to $4.88 across the transactions (footnotes F2/F3). The filer can provide per‑trade price breakdown on request.
- Shares owned after the transactions are not specified in the excerpt of the filing provided.
- Filing: Form 4 filed Apr 14, 2026. The filing does not indicate a late filing.
Context
These sales were expressly made to cover tax withholding obligations related to vesting restricted stock units and were executed under a Rule 10b5‑1 plan. Such tax‑withholding sales are common and generally treated as administrative/routine rather than a clear signal about an insider’s view of the company.
Insider Transaction Report
Form 4
Menu Philippe
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-04-10$4.68/sh−3,725$17,441→ 272,996 total - Sale
Ordinary Shares
[F1][F3]2026-04-13$4.76/sh−1,000$4,764→ 271,996 total - Sale
Ordinary Shares
[F4][F3]2026-04-13$4.76/sh−3,400$16,198→ 268,596 total
Footnotes (4)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.61 to $4.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.62 to $4.88, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-04-14